Open (also known as webisOpen on X, collective includes RSS3) is transforming virological research and decentralized science ...

Filed provisional patent application, further expanding IP portfolio ...

The antisense oligonucleotides market is set to grow at a 6.6% CAGR, reaching $5.5 billion by 2033. Expanding applications in ...

Anavex Life Sciences' ANAVEX 2-73 shows promise in treating Alzheimer's, with strong efficacy in slowing cognitive and ...

The goal is to democratize RNA technology,” said one of the professors behind the project, known as BioFoundry.

In everyday life, when things turn out the opposite of what you expect, it's usually cause for frustration. In science, it's ...

New findings point to an opportunity to improve therapies that use small RNAs to silence disease-causing genes, potentially ...

The data shows that RNA interacts with a mitochondrial protein complex to trigger immune response pathways when viral RNA is ...

GreenLight Biosciences' Mark Singleton shares insight into the company's long-term vision to make RNA technology a ...

"While protein-protein interactions and protein modifications are critical for antiviral signaling through the MAVS signalosome," Ram Savan noted, "our research highlights the significant role of ...

Nanopore sequencing devices are small enough to fit in the palm of a hand and can process RNA samples in real time. This portability and efficiency mean that researchers can analyze minimal amounts of ...